Lanean...
Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients
Cutaneous melanoma is one of the highest incident‐rate cancers with increasing prevalence in Western societies. Despite the advent of new approved therapeutics, the 5‐year overall survival rate of stage IV melanoma patients remains below 15%. Current treatments for late stage disease have shown high...
Gorde:
| Argitaratua izan da: | Mol Oncol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5307330/ https://ncbi.nlm.nih.gov/pubmed/26778792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2015.12.008 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|